Continue reading this on our app for a better experience

Open in App
Floating Button
Home News Deals, joint ventures & alliances

UG Healthcare to set up medical diagnostic centre in Nigeria through JV

Felicia Tan
Felicia Tan • 1 min read
UG Healthcare to set up medical diagnostic centre in Nigeria through JV
The initial capital of the JV company, Health Focus Diagnostics Nigeria (PTY) Limited, is NGN10 million ($31,000). Photo: Bloomberg
Font Resizer
Share to Whatsapp
Share to Facebook
Share to LinkedIn
Scroll to top
Follow us on Facebook and join our Telegram channel for the latest updates.

UG Healthcare’s 75%-owned subsidiary, Uni-Medical Healthcare Limited (UNIGLOVES Nigeria), has incorporated a joint venture (JV) partnership with Health Focus Diagnostics GmbH to set up a medical diagnostic centre in the state of Enugu, Nigeria.

The initial capital of the JV company, Health Focus Diagnostics Nigeria (PTY) Limited, is NGN10 million ($31,000).

UNIGLOVES Nigeria will have a 51% stake in the JVCo while Health Focus and a private unnamed individual investor will have a stake of 34% and 15% respectively.

The incorporation of the JVCo presents an opportunity for UG Healthcare to expand its business into a non-gloves healthcare related sector in Nigeria through a well-established partner like Health Focus.

The diagnostic centre will be set up in a ready-built and ready-to-use property that UNIGLOVES Nigeria owns in Enugu, Nigeria.

The investment in the JV will be funded through internal resources.

See also: Silverlake Axis launches in Vietnam with first official distributor partnership

Shares in UG Healthcare closed 1 cent higher or 5% up at 21 cents on Dec 27.

Highlights

Re test Testing QA Spotlight
1000th issue

Re test Testing QA Spotlight

Get the latest news updates in your mailbox
Never miss out on important financial news and get daily updates today
×
The Edge Singapore
Download The Edge Singapore App
Google playApple store play
Keep updated
Follow our social media
© 2024 The Edge Publishing Pte Ltd. All rights reserved.